Evidence map›Paper›PMID 40557793›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

MGPT: A Multi-task Graph Prompt Learning Framework for Drug Discovery.

Yang Li, Youhan Sun, Xinyu Qin, Xin Gao, Guohua Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. MGPT: A Multi-task Graph Prompt Learning Framework for Drug Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yang LiCollege of Computer and Control Engineering, Northeast Forestry University, Hexing Road, Harbin, Heilongjiang, 150040, China.
Youhan SunCollege of Computer and Control Engineering, Northeast Forestry University, Hexing Road, Harbin, Heilongjiang, 150040, China.
Xinyu QinCollege of Computer and Control Engineering, Northeast Forestry University, Hexing Road, Harbin, Heilongjiang, 150040, China.
Xin GaoComputer Science Program, Computer, Electrical and Mathematical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Kingdom of Saudi Arabia.
Guohua WangCollege of Computer and Control Engineering, Northeast Forestry University, Hexing Road, Harbin, Heilongjiang, 150040, China.ORCID https://orcid.org/0000-0001-7381-2374

Funding

National Natural Science Foundation of China 32470687National Natural Science Foundation of China 62450112National Science Fund for Distinguished Young Scholars 62225109Natural Science Foundation of Heilongjiang Province ZD2024F001
6 · The paper itself

Abstract

Predicting accurate drug associations, including drug-target interactions, drug side effects, and drug-disease relationships, is crucial in biomedical research and precision medicine. Recently, the research community is increasingly adopted graph representation learning methods to investigate drug associations. However, translating advancements in graph pre-training to the domain of drug development faces significant challenges, particularly in multi-task learning and few-shot scenarios. A unified Multi-task Graph PrompT (MGPT) learning model is proposed providing generalizable and robust graph representations for few-shot drug association prediction. MGPT constructs a heterogeneous graph network using different entity pairs as nodes and utilizes self-supervised contrastive learning of sub-graphs in pre-training. For downstream tasks, MGPT employs learnable functional prompts, embedded with task-specific knowledge, to enable robust performance across a range of tasks. MGPT demonstrates the ability of seamless task switching and outperforms competitive approaches in few-shot scenarios. MGPT emerges as a robust solution to the complexities of multi-task learning and the challenges associated with limited data in drug development.

Indexed as

Drug DiscoveryMachine LearningHumansdrug associationsheterogeneous graph networkmulti‐task prompt tuningself‐supervised contrastive learning

Identifiers

PMID40557793
PMCPMC12442687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.